Investing.com -- Meta Platforms is planning to restructure its artificial intelligence efforts for the fourth time in six months, according to The Information, citing three people familiar with the ...

Investing.com -- Lockheed Martin Space has been awarded a $110.9 million contract modification for Trident II missile ...

Investing.com -- Lyft (NASDAQ:LYFT) stock rose 9% Friday, marking its biggest gain since May, following the announcement that ...

Investing.com -- Canada’s Department of Finance released draft tax legislation on Friday that maintains several economic policies proposed by the previous administration, showing continuity under ...

S&P expects Angola to meet its upcoming Eurobond repayment in November 2025, supported by assets totaling $21.4 billion (about 19% of GDP). This includes $15.1 billion in foreign currency reserves, $1 ...

Investing.com -- S&P Global Ratings has affirmed Tajikistan’s ’B’ long-term and ’B’ short-term foreign and local currency sovereign credit ratings with a stable outlook on Friday.

Investing.com -- S&P Global Ratings raised Lebanon’s long-term local currency credit rating to ’CCC’ from ’CC’ on Thursday, while maintaining a stable outlook and affirming its foreign currency rating ...

Investing.com -- NusaTrip Incorporated (NASDAQ:NUTR), a travel ecosystem specializing in Southeast Asia and Asia-Pacific, began trading on the Nasdaq Capital Market Friday at $3.58 per share, falling ...

Via has shown improving financial metrics while maintaining growth. Its net loss margin improved from (47)% in 2023 to (27)% in 2024, while Adjusted EBITDA margin improved from (37)% to (16)% during ...

TCPC’s leverage increased to 1.60x in the second quarter, the highest among Fitch’s rated BDC peer group. The company’s ...

Investing.com -- Trading was halted in Tonix Pharmaceuticals (NASDAQ:TNXP) stock Friday ahead of a major announcement that the U.S. Food and Drug Administration (FDA) has approved Tonmya for the ...

Investing.com -- Bausch Health Companies Inc (NYSE:BHC) stock surged 11.3% after Paulson Capital Inc. and its affiliates increased their ownership stake in the pharmaceutical company.